News

CIT GAP Funds Invests in 4stay to Increase Lodging Opportunities on College Campuses

Online marketplace for student housing connects students, interns, and professionals with local hosts, roommates, and room providers

CIT GAP Funds Invests in Metallum3D to Increase the Accessibility of Cost Effective Metal 3D Printing

Startup offers affordable metal 3D printing materials and services to reduce the traditional limitations of this technology​

CIT GAP Funds Invests in Tympanogen to Advance Modern-Day Medical Treatments for Ear, Nose and Throat

The Center for Innovative Technology (CIT) announced today that CIT GAP Funds has invested in Richmond, VA-based Tympanogen, Inc., a medical technology...

Portfolio

CIT’s GAP Venture Fund began deploying capital in mid-2005. The Fund invests in high-potential early stage technology companies accelerating their path to significant growth through active partnership and company development.




Piedmont Bioproducts

Gretna, Virginia
CEO: Ken Moss
Company Status: Private
Investment Status: Current
GAP Fund: GAP Fund I
Renewable resource company that will generate products derived from energy crops grown by farmers in a closed loop system within a specified radius of its refinery.



GAP Funds portfolio companies are early stage companies with corresponding investment risk profiles; CIT assumes no liability for any investment by any person in any GAP Funds Portfolio company.